Monitoring Trade Between the Community and Third Countries in Drug Precursors: Initial Appraisal of the Commission's Impact Assessment

Briefing 15-03-2013

This note seeks to provide an initial analysis of the strengths and weaknesses of the European Commission's Impact Assessment (IA) accompanying the proposal for a Regulation amending Council Regulation (EC) No 111/2005 laying down rules for the monitoring of trade between the Community and third countries in drug precursors. Drug precursors are chemical substances that may be produced for licit purposes, but which can be misused for illegal drug production. A specific regulatory framework has been set up both at international level and within the EU to prevent the diversion of drug precursors to illicit drug production.